This study describes the method of intra-articular injection of mono-iodoacetate in rats and discusses the resulting pain-related behaviors and histopathological changes, which provide references for future applications.
A subscription to JoVE is required to view this content. Sign in or start your free trial.
Method Article
This study describes the method of intra-articular injection of mono-iodoacetate in rats and discusses the resulting pain-related behaviors and histopathological changes, which provide references for future applications.
The current animal models of osteoarthritis (OA) can be divided into spontaneous models and induced models, both of which aim to simulate the pathophysiological changes of human OA. However, as the main symptom in the late stage of OA, pain affects the patients' daily life, and there are not many available models. The mono-iodoacetate (MIA)-induced model is the most widely used OA pain model, mainly used in rodents. MIA is an inhibitor of glyceraldehyde-3-phosphate dehydrogenase, which causes chondrocyte death, cartilage degeneration, osteophyte, and measurable changes in animal behavior. Besides, expression changes of matrix metalloproteinase (MMP) and pro-inflammatory cytokines (IL1 β and TNF α) can be detected in the MIA-induced model. Those changes are consistent with OA pathophysiological conditions in humans, indicating that MIA can induce a measurable and successful OA pain model. This study aims to describe the methodology of intra-articular injection of MIA in rats and discuss the resulting pain-related behaviors and histopathological changes.
Osteoarthritis (OA) is the most common joint disease in the world, affecting an estimated 10-12% populations in adults1. The most generally involved joint is the knee, and OA has a higher incidence in older adults, especially women2. As a chronic disease, OA develops progressively over decades into joint failure with symptoms such as cartilage loss, synovial inflammation, osteophytosis, decreased function, and chronic pain3. According to the World Health Organization (WHO), OA is the fourth most prevalent disease in females and the eighth most prevalent disease in males. By 2020, OA may become the....
Access restricted. Please log in or start a trial to view this content.
Procedures involving animal subjects have been approved by the Medical Norms and Ethics Committee of Zhejiang Chinese Medical University and are in accordance with the China legislation on the use and care of laboratory animals.
1. Intra-articular injection of mono-iodoacetate in the knee
Access restricted. Please log in or start a trial to view this content.
With this methodology, we established an OA pain model in the rat and detected the resulting changes. MWT and TWL reflected mechanical allodynia and thermal hyperalgesia, respectively. As shown in Figure 1, MIA induced mechanical allodynia and thermal hyperalgesia present in a dose-dependent manner. Remarkably, the decrease of MWT reached a peak from 21 days to 28 days, and then rebounded, suggesting that joint repair may occur at this stage, but MWT of 3 mg MIA group was still at a low leve.......
Access restricted. Please log in or start a trial to view this content.
The rat model of OA induced by MIA is a well-established, widely used model. Intra-articular injection of MIA initially causes severe and acute inflammation, which gives rise to the longer and degenerative phase of OA17,18. In this research, we measured nociceptive sensitivity by MWT and TWL, and assessed gait alterations with an imaging system. Previous reports found that the injection of MIA could raise the sensitivity of afferent knee joint fibers leading to n.......
Access restricted. Please log in or start a trial to view this content.
The authors have nothing to disclose.
This study was funded by the Zhejiang Provincial Natural Science Foundation of China (Grant No: LY17H270016), the National Natural Science Foundation of China (Grant No: 81774331, 81873049, and 81673997), and the Zhejiang Provincial Science and Technology Project of Traditional Chinese Medicine of China (Grant No: 2013ZQ007 and 2016ZZ011).
....Access restricted. Please log in or start a trial to view this content.
| Name | Company | Catalog Number | Comments |
|---|---|---|---|
| Anti-Collagen II antibody | Abcam(UK) | 34712 | Primary antibody for immunohistochemistry (IHC) |
| Anti-Collagen X (Col10) antibody | Abcam(UK) | 49945 | Primary antibody for IHC |
| DigiGait Imaging System | Mouse Specifics (Boston, MA, USA) | Equipment for gait patterns analyses | |
| Eosin | Sigma-Aldrich | 861006 | The dye for HE staining |
| Fast Green FCF | Sigma-Aldrich | F7252 | The dye for SO staining |
| Goat anti-mouse antibody | ZSGQ-BIO (Beijing, China) | PV-9002 | Secondary antibody for IHC |
| Goat anti-rabbit antibody | ZSGQ-BIO (Beijing, China) | PV-9001 | Secondary antibody for IHC |
| Hematoxylin | Sigma-Aldrich | H3163 | The dye for HE staining |
| MIA | Sigma-Aldrich | I4386-10G | powder |
| MMP13 | Cell Signaling Technology, Inc. (Danvers, MA, USA) | 69926 | Primary antibody for IHC |
| Modular tissue embedding center | Thermo Fisher Scientific (USA) | EC 350 | Produce paraffin blocks. |
| Plantar Test apparatus | UgoBasile (Italy) | 37370 | Equipment for TWL assay |
| PrimeScript RT reagent Kit (Perfect Real Time) | TaKaRa Biotechnology Co. Ltd. (Dalian, China) | RR037A | Extracte total RNA from cultured cells |
| Rotary and Sliding Microtomes | Thermo Fisher Scientific (USA) | HM325 | Precise paraffin sections. |
| Safranin-O | Sigma-Aldrich | S2255 | The dye for SO staining |
| Tissue-Tek VIP 5 Jr | Sakura (Japan) | Vacuum Infiltration Processor |
Access restricted. Please log in or start a trial to view this content.